In a recent study posted to the bioRxiv* preprint server, researchers demonstrated that coronavirus disease 2019 (COVID-19) convalescent plasmas (CCPs) with low neutralizing and high fragment ...
Therapeutic antibodies are now the major class of successful protein drugs with many more in development to target a variety of major diseases. An important and desirable biological activity of most ...
Creative Biolabs, a global leader in antibody engineering, today announced its optimization of ADCC and Fc-mediated effector functions. SHIRLEY, NY, UNITED STATES ...
Post-translational modifications (PTMs), particularly glycosylation, affect a protein drug’s activity, effectiveness, and safety, but not always in predictable ways. Some glycans are known to be ...
A new study published on the preprint server medRxiv* finds improved Fc cross-reactivity against certain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern (VOCs).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results